With continuous medical supervision and personalized care, tirzepatide can be a promising part of a long-term weight loss strategy
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is the first drug in a family of medicines that target two hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) that are involved in maintaining healthy blood sugar levels and sending signals of satiety from the gut to the brain
Our providers offer consultations to discuss your options
Its recommended to focus on consuming nutrient-dense, low-calorie foods, such as vegetables, lean proteins, whole grains, and healthy fats
Clinical data on tirzepatide in type 2 diabetesthe SURPASS clinical trial program Early clinical studies with tirzepatide revealed a marked and dose-dependent reduction of HbA1c and further glycemic parameters in patients with T2D in various ethnic cohorts (clinical trials registration numbers NCT03322631, NCT03131687, and NCT03311724) (6668)
Here, we asked experts to break down the key differences between Zepbound vs
